Ann Dermatol.  2019 Dec;31(6):640-644. 10.5021/ad.2019.31.6.640.

Skin Disease in Korean Human Immunodeficiency Virus Patient

• Jung HJ
• Ahn JY
• Jang DH
• Lee JI
• Bae JY
• Park MY

• KMID: 2461986
• DOI: http://doi.org/10.5021/ad.2019.31.6.640

Abstract

BACKGROUND
In Korea, new human immunodeficiency virus (HIV) patients continue to be diagnosed. Due to the development of highly active anti-retroviral therapy (HAART) and lengthening of survival period of infected person, the aspect of skin diseases of HIV-infected patients is also changing.
OBJECTIVE
To determine skin diseases of HIV-infected patients according to immune status and the relationship between folliculitis and HAART drug.
METHODS
Subjects were HIV-infected patients who were treated in the department of dermatology from September 1, 2008 to August 31, 2018. Medical records of 376 subjects were retrospectively analyzed.
RESULTS
Of 376 patients were studied, tinea infection, folliculitis, and seborrheic dermatitis were the most common regardless of their CD4 T cell counts or treatment group (initial treatment or retreatment). Seborrheic dermatitis, irritant contact dermatitis, and pruritic papular eruption were significantly more common in patients with CD4+T cells less than 200×106 cells/L while warts were significantly more frequent in patients with CD4+T cells greater than 200×106 cells/L. Most HAART agents were found to be helpful in reducing the incidence of folliculitis.
CONCLUSION
There were many skin diseases in HIV patients, different from previous studies. In our study, the top three diagnoses were tinea infection, folliculitis, and seborrheic dermatitis. HAART medication was helpful in reducing folliculitis. These changes will require different treatments for skin diseases in HIV patients.

Keyword

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Skin disease

MeSH Terms

Acquired Immunodeficiency Syndrome
Antiretroviral Therapy, Highly Active
Cell Count
Dermatitis, Contact
Dermatitis, Seborrheic
Dermatology
Diagnosis
Folliculitis
HIV*
Humans*
Incidence
Korea
Medical Records
Retrospective Studies
Skin Diseases*
Skin*
Tinea
Warts

Reference

1. Kim MS, Ahn JY, Shin HS, Park MY. Frequency of skin disorders in HIV-infected patients and their relationship to CD4+ T lymphocyte counts. Korean J Dermatol. 2013; 51:771–775.

2. Bhatia MS, Grover V, Gupta R. A textbook on HIV infection and AIDS in adolescents. New Delhi: New Age International. 2008; 1–2.

3. Uthayakumar S, Nandwani R, Drinkwater T, Nayagam AT, Darley CR. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br J Dermatol. 1997; 137:595–598. PMID: 9390338.

4. Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet. 1996; 348:659–663. PMID: 8782758.

5. Korea Federation for HIV/AIDS Prevention [Internet]. Seoul: Korea Federation for HIV/AIDS Prevention;2019. cited 2019 Jan 10. Available from: http://www.kaids.or.kr/?r=main.

6. Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc. 2011; 14:5. PMID: 21261982.

7. Kim TG, Lee KH, Oh SH. Skin disorders in Korean patients infected with human immunodeficiency virus and their association with a CD4 lymphocyte count: a preliminary study. J Eur Acad Dermatol Venereol. 2010; 24:1476–1480. PMID: 20384683.

8. Scott C, Staughton RC, Bunker CJ, Asboe D. Acne vulgaris and acne rosacea as part of immune reconstitution disease in HIV-1 infected patients starting antiretroviral therapy. Int J STD AIDS. 2008; 19:493–495. PMID: 18574128.

9. Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One. 2012; 7:e40623. PMID: 23152745.

10. Annam V, Yelikar BR, Inamadar AC, Palit A, Arathi P. Clinicopathological study of itchy folliculitis in HIV-infected patients. Indian J Dermatol Venereol Leprol. 2010; 76:259–262. PMID: 20445296.

11. Farsani TT, Kore S, Nadol P, Ramam M, Thierman SJ, Leslie K, et al. Etiology and risk factors associated with a pruritic papular eruption in people living with HIV in India. J Int AIDS Soc. 2013; 16:17325. PMID: 24004854.

12. Afonso JP, Tomimori J, Michalany NS, Nonogaki S, Porro AM. Pruritic popular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study. J Am Acad Dermatol. 2012; 67:269–275. PMID: 22521200.

13. Okada S, Fujimura T, Furudate S, Kambayashi Y, Kikuchi K, Aiba S. Immunosuppression-associated eosinophilic pustular folliculitis (IS-EPF) developing after Highly Active Anti-Retroviral Therapy (HAART): the possible mechanisms through CD163+ M2 macrophages. Eur J Dermatol. 2013; 23:713–714. PMID: 24213586.

14. Cha SH, Jeong SW, Jung BH, Park SD. Chronic recurrent folliculitis with atypical hyperpigmented scarring in an AIDS patient. Ann Dermatol. 1999; 11:55–58.

15. Shin BS, Na CH, Song IG, Choi KC. A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol. 2010; 22:199–202. PMID: 20548914.

16. Lee DK, Chon KJ, Son SJ, Kim DJ, Cho DI. A case of AIDS-related Kaposi's sarcoma. Ann Dermatol. 2000; 12:211–214.